Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%

NCT02446223 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Inggenol Mebutate 0.015%

Sponsor

Goldman, Butterwick, Fitzpatrick and Groff

Collaborators

[object Object]